Delivery Order SPE2DR25D3501-SPE2DR26FM2WP
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,078.93 on January 20, 2026, to supply Jardiance 25 mg tablets (90-count) to the Defense Logistics Agency with an ultimate completion date of January 21, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,732.24 on January 7, 2026, for the supply of Jardiance 25 mg tablets (90-count packages). The contract is a firm fixed-price delivery order with no set-aside designation, awarded by the Defense Logistics Agency (DLA), the Department of Defense's supply chain management organization responsible for medical procurement. Performance will be completed...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on November 6, 2025, for the supply of Jardiance 25 mg tablets (90-count) with a ceiling value of $11,878.85. This competitive, firm fixed-price delivery order is set to be completed by November 7, 2025, and represents a single-line procurement under AmerisourceBergen's larger pharmaceutical supply framework with the federal...
- AmerisourceBergen Drug Corp was awarded a delivery order on September 22, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply Jardiance 10 mg tablets in a 90-count package. The award, valued at $2,531.61, represents a firm fixed-price delivery order with no set-aside designation and a completion date of September 23, 2025. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $8,908.09 by the Defense Logistics Agency for 90 tablets of Jardiance 10 mg, a diabetes management medication. The contract is a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and represents a non-set-aside competitive award. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 15, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply Jardiance 10 mg tablets (90-count packaging). The contract carries a ceiling value of $48,577.98 and employs firm fixed price terms with an ultimate completion date of August 18, 2025. This non-set-aside award was competitively awarded and represents a child delivery order...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order on January 13, 2026, by the Defense Logistics Agency to supply 90 tablets of Jardiance 10 mg, a diabetes medication. This $4,270.31 firm fixed-price contract is a non-set-aside award, demonstrating AmerisourceBergen's competitive capability to serve federal medical procurement requirements. The order is scheduled for completion by January 14, 2026, with performance taking place at the company's corporate...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order on January 21, 2026, by the Defense Logistics Agency to supply 90 tablets of Jardiance 25 mg, a diabetes medication. This firm fixed-price delivery order, valued at $6,292.99, is scheduled for completion by January 22, 2026, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, leveraging...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,056.65 by the Defense Logistics Agency on November 7, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This competitively awarded, firm fixed-price contract carries an ultimate completion date of November 10, 2025, and includes no set-aside designation. The place of performance is AmerisourceBergen's corporate office in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency for 90 tablets of Jardiance 10mg on November 3, 2025, with a ceiling value of $7,923.45 and an ultimate completion date of December 2, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FM2WPDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,873.63 on January 21, 2026, for the supply of Jardiance 10 mg tablets (90-count packages) to support federal medical procurement needs. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open and competitive procurement. The funding agency is the Defense Logistics Agency (DLA), which procures pharmaceutical products and medical supplies to support military and veteran healthcare systems. Performance of this delivery order is scheduled for completion by January 22, 2026. This delivery order is executed under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031. This comprehensive IDC serves as the primary vehicle for delivering a broad range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs globally. The award reflects AmerisourceBergen's established capability to efficiently fulfill federal pharmaceutical procurement requirements through a flexible and expansive contract vehicle that supports Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 1/20/26 |